Entropy is a Simple Measure of the Antibody Profile and is an Indicator of Health Status: A Proof of Concept

We have previously shown that the diversity of antibodies in an individual can be displayed on chips on which 130,000 peptides chosen from random sequence space have been synthesized. This immunosignature technology is unbiased in displaying antibody diversity relative to natural sequence space, and has been shown to have diagnostic and prognostic potential for a wide variety of diseases and vaccines. Here we show that a global measure such as Shannon’s entropy can be calculated for each immunosignature. The immune entropy was measured across a diverse set of 800 people and in 5 individuals over 3 months. The immune entropy is affected by some population characteristics and varies widely across individuals. We find that people with infections or breast cancer, generally have higher entropy values than non-diseased individuals. We propose that the immune entropy as measured from immunosignatures may be a simple method to monitor health in individuals and populations.

[1]  Joseph Barten Legutki,et al.  Evaluation of Biological Sample Preparation for Immunosignature-Based Diagnostics , 2012, Clinical and Vaccine Immunology.

[2]  Phillip Stafford,et al.  A general method for characterization of humoral immunity induced by a vaccine or infection. , 2010, Vaccine.

[3]  Phillip Stafford,et al.  Peptide based diagnostics: are random-sequence peptides more useful than tiling proteome sequences? , 2015, Journal of immunological methods.

[4]  D. Kebede,et al.  The HIV epidemic and the state of its surveillance in Ethiopia. , 2000, Ethiopian medical journal.

[5]  M. R. Evans,et al.  Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  Michael J. Franklin,et al.  CV , 2013 .

[7]  Valentin Dinu,et al.  Statistical methods for analyzing immunosignatures , 2011, BMC Bioinformatics.

[8]  Peter M. A. Sloot,et al.  Topological Characterization of Complex Systems: Using Persistent Entropy , 2015, Entropy.

[9]  Run-cheng Li,et al.  Epitope screening of the PCV2 Cap protein by use of a random peptide-displayed library and polyclonal antibody. , 2013, Virus research.

[10]  M. Mrksich,et al.  Peptide chips for the quantitative evaluation of protein kinase activity , 2002, Nature Biotechnology.

[11]  Phillip Stafford,et al.  Feasibility of an early Alzheimer's disease immunosignature diagnostic test , 2013, Journal of Neuroimmunology.

[12]  Phillip Stafford,et al.  Comparative study of classification algorithms for immunosignaturing data , 2012, BMC Bioinformatics.

[13]  Edoardo Cervoni,et al.  Hepatitis C , 1998, The Lancet.

[14]  Rebecca F. Halperin,et al.  Exploring Antibody Recognition of Sequence Space through Random-Sequence Peptide Microarrays , 2010, Molecular & Cellular Proteomics.

[15]  Andrea Pagnani,et al.  Maximum-Entropy Models of Sequenced Immune Repertoires Predict Antigen-Antibody Affinity , 2016, PLoS Comput. Biol..

[16]  R. Hilgers,et al.  3. Studies of Cancer in experimental Animals , 2008 .

[17]  Valeriy Domenyuk,et al.  A Technology for Developing Synbodies with Antibacterial Activity , 2013, PloS one.

[18]  Phillip Stafford,et al.  Application of immunosignatures to the assessment of Alzheimer's disease , 2011, Annals of neurology.

[19]  O. Erhabor,et al.  The risk of transfusion-transmissible viral infections in the Niger-Delta area of Nigeria , 2005 .

[20]  Joseph Barten Legutki,et al.  Immunosignatures can predict vaccine efficacy , 2013, Proceedings of the National Academy of Sciences.

[21]  S. Mustapha,et al.  THE PREVALENCE OF HEPATITIS B SURFACE ANTIGENAEMIA IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV)INFECTION IN GOMBE, NIGERIA , 2004 .

[22]  T. S. Lim,et al.  Identification of Peptide Based Inhibitors for α-Amylase by Phage Display , 2015, International Journal of Peptide Research and Therapeutics.

[23]  Babak Bakhshinejad,et al.  Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library , 2016, Amino Acids.

[24]  C. Janot,et al.  Etude épidémiologique de la sérologie VIH des donneurs de sang dans cinq départements du nord-est de la France (1985–1989) , 1989 .

[25]  P. Stafford,et al.  Application of Immunosignatures for Diagnosis of Valley Fever , 2014, Clinical and Vaccine Immunology.

[26]  J. Avery.  Critical review. , 2006, The Journal of the Arkansas Medical Society.

[27]  M. Manjili,et al.  Tumor immunoediting and immunosculpting pathways to cancer progression. , 2007, Seminars in cancer biology.

[28]  Phillip Stafford,et al.  Scalable high-density peptide arrays for comprehensive health monitoring , 2014, Nature Communications.

[29]  Beth Dow,et al.  The Dynamic Range , 2015 .

[30]  D. Pierson,et al.  Spaceflight modulates gene expression in the whole blood of astronauts , 2016, npj Microgravity.

[31]  N. Ukwandu,et al.  Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria. , 1997, East African medical journal.

[32]  Phillip Stafford,et al.  Immunosignature system for diagnosis of cancer , 2014, Proceedings of the National Academy of Sciences.

[33]  Rebecca F. Halperin,et al.  Physical Characterization of the “Immunosignaturing Effect” , 2012, Molecular & Cellular Proteomics.

[34]  Using Frameshift Peptide Arrays for Cancer Neo-Antigens Screening , 2018, Scientific Reports.

[35]  K. A. Noren,et al.  Construction of high-complexity combinatorial phage display peptide libraries. , 2001, Methods.

[36]  N. Shire,et al.  Epidemiology of Hepatitis C Virus: A Battle on New Frontiers. , 2015, Gastroenterology clinics of North America.

[37]  Erdogan Gulari,et al.  High density peptide microarrays. In situ synthesis and applications , 2004, Molecular Diversity.

[38]  Phillip Stafford,et al.  Immunosignaturing: a critical review. , 2013, Trends in biotechnology.

[39]  M. Houghton,et al.  Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. , 1990, JAMA.

[40]  Qi-hao Zhang,et al.  A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder , 2015, Applied Microbiology and Biotechnology.

[41]  Charles M. Perou,et al.  Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.

[42]  A. Adjei,et al.  Prevalence of antibodies to syphilis among blood donors in Accra, Ghana. , 2003, Japanese journal of infectious diseases.

[43]  Phillip Stafford,et al.  Immunosignaturing microarrays distinguish antibody profiles of related pancreatic diseases , 2013 .

[44]  Ping Zhu,et al.  MimoDB 2.0: a mimotope database and beyond , 2011, Nucleic Acids Res..

[45]  N. Adey,et al.  An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets. , 1993, Gene.

[46]  R. Taherkhani,et al.  Epidemiology of hepatitis C virus in Iran. , 2015, World journal of gastroenterology.